Dutasteride
Prescription prostate drug also used against hair loss; it lowers the hormone DHT by about 90–95%.
The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Related comparisons
Finasteride vs DutasterideDETAILED OVERVIEW
What is Dutasteride?
Dutasteride is a prescription medicine, used both as a capsule and as a solution applied to the skin. It was approved for an enlarged prostate; for hair loss it is used only off-label in the USA and the EU, while in South Korea and Japan it is officially approved.
It blocks both types of the enzyme that turns testosterone into DHT (dihydrotestosterone, a strong male hormone), so it lowers DHT levels by about 90–95%. In one large study it increased hair count more than finasteride or placebo, but this takes months to develop. Reduced sex drive, erection problems and ejaculation problems each occur in about 1–4% of users; depression may also occur. It must not be used in pregnancy, because it can harm the development of a male baby's genitals; the contents of a leaking capsule can be absorbed through the skin, so a pregnant woman must not touch it.
ATC code
G04CB02
Prescription status
Prescription (Rx); off-label for AGA
Mechanism of action
Dual 5-alpha-reductase (I + II) inhibition, ~90-95% DHT reduction
Half-life
~5 weeks (terminal) – far longer than finasteride
Onset of action
3-6 months (hair stabilization), 6-12 months (regrowth)
No anecdote collected yet.
Data console
Lab data
Gubelin Harcha W, Barboza Martínez J, Tsai TF, et al. . A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J Am Acad Dermatol. 2014;70(3):489-498..
Shanshanwal SJ, Dhurat RS. . Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study. Indian J Dermatol Venereol Leprol. 2017;83(1):47-54..
Hirshburg JM, Kelsey PA, Therrien CA, et al. . Adverse effects and safety of 5-alpha reductase inhibitors (finasteride, dutasteride): a systematic review. J Clin Aesthet Dermatol. 2016;9(7):56-62..
Safety
Side effects, stop signs, contraindications
Side effects · 6
- Sexual side effects: decreased libido, erectile dysfunction and ejaculation disorder (~1-4% each); sometimes slightly more frequent than with finasteride due to the fuller androgen blockade, mostly reversible after discontinuation.
- Breast changes: gynaecomastia, breast tenderness and pain; rarely a breast lump or nipple discharge that must be evaluated.
- Mood disorders: depression and decreased libido reported; a class warning for 5-alpha-reductase inhibitors, discontinue and seek medical advice if psychiatric symptoms occur.
- PSA decreases by ~50%: prostate-specific antigen becomes falsely low, so during prostate cancer screening the measured PSA must be doubled to avoid a false negative.
- Hypersensitivity and skin reactions: rash, pruritus, urticaria, localized edema and (rarely) angioedema; immediate discontinuation if an allergic reaction occurs.
- Slightly increased incidence of high-grade prostate cancer (Gleason 8-10) in the REDUCE trial, while overall prostate cancer risk fell; with no difference in overall survival.
Contraindications · 4
- Pregnancy
- Women of childbearing potential
- Severe hepatic impairment
- Hypersensitivity
Related Hair & Skin
Same therapeutic category
Studies
Related research and clinical findings
A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia
Gubelin Harcha W, Barboza Martínez J, Tsai TF, et al.
Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study
Shanshanwal SJ, Dhurat RS.
Adverse effects and safety of 5-alpha reductase inhibitors (finasteride, dutasteride): a systematic review
Hirshburg JM, Kelsey PA, Therrien CA, et al.
Telegram
Have a question about Dutasteride?
Educational hair and skin info from official sources (PubMed, FDA, EMA). Does NOT replace medical consultation. Talk to a dermatologist!
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.
